NCT02120222 2023-04-04
KPT-330
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
Clinical Trials
5 trialsNCT02548780 2020-01-27
LifePearl-Doxo Pharmacokinetic (PK) Study
Terumo Europe N.V.
Phase NA Completed
NCT00727233 2019-12-12
Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00989586 2017-02-06
Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 1/2 Completed
NCT00323323 2017-01-20
CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas
Ohio State University Comprehensive Cancer Center
Phase 1 Completed